Fri, May 12, 2023
Thu, May 11, 2023
Wed, May 10, 2023

Geulah Livshits Maintained (SNTI) at Strong Buy with Decreased Target to $60 on, May 11th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-60-on-may-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Geulah Livshits of Chardan Capital, Maintained "Senti Biosciences, Inc." (SNTI) at Strong Buy with Decreased Target from $70 to $60 on, May 11th, 2023.

Geulah has made no other calls on SNTI in the last 4 months.



There is 1 other peer that has a rating on SNTI. Out of the 1 peers that are also analyzing SNTI, all agrees with Geulah's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $20 on, Friday, March 24th, 2023

Publication Contributing Sources